Villanueva et al., 2015 - Google Patents
Exome sequencing in an admixed isolated population indicates NFXL1 variants confer a risk for specific language impairmentVillanueva et al., 2015
View HTML- Document ID
- 345518369815520687
- Author
- Villanueva P
- Nudel R
- Hoischen A
- Fernández M
- Simpson N
- Gilissen C
- Reader R
- Jara L
- Echeverry M
- Francks C
- Baird G
- Conti-Ramsden G
- O’Hare A
- Bolton P
- Hennessy E
- SLI Consortium
- Palomino H
- Carvajal-Carmona L
- Veltman J
- Cazier J
- De Barbieri Z
- Fisher S
- Newbury D
- Publication year
- Publication venue
- PLoS genetics
External Links
Snippet
Children affected by Specific Language Impairment (SLI) fail to acquire age appropriate language skills despite adequate intelligence and opportunity. SLI is highly heritable, but the understanding of underlying genetic mechanisms has proved challenging. In this study, we …
- 201000002959 specific language impairment 0 title abstract description 76
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6881—Hybridisation probes for tissue and cell typing, e.g. HLA probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for mutation or polymorphism detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Villanueva et al. | Exome sequencing in an admixed isolated population indicates NFXL1 variants confer a risk for specific language impairment | |
Rafehi et al. | Bioinformatics-based identification of expanded repeats: a non-reference intronic pentamer expansion in RFC1 causes CANVAS | |
Nudel et al. | Genome‐wide association analyses of child genotype effects and parent‐of‐origin effects in specific language impairment | |
Chen et al. | Next-generation DNA sequencing identifies novel gene variants and pathways involved in specific language impairment | |
Zarrei et al. | A copy number variation map of the human genome | |
McMichael et al. | Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy | |
Grozeva et al. | Targeted next‐generation sequencing analysis of 1,000 individuals with intellectual disability | |
Bryois et al. | Cis and trans effects of human genomic variants on gene expression | |
Berko et al. | Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder | |
Kehr et al. | Diversity in non-repetitive human sequences not found in the reference genome | |
Takata et al. | Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy | |
Ben-David et al. | Identification of a functional rare variant in autism using genome-wide screen for monoallelic expression | |
van der Zwaag et al. | Gene-network analysis identifies susceptibility genes related to glycobiology in autism | |
Mathews et al. | Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36 | |
Trabzuni et al. | Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus | |
Peter et al. | Genetic candidate variants in two multigenerational families with childhood apraxia of speech | |
Walters et al. | Rare genomic structural variants in complex disease: lessons from the replication of associations with obesity | |
Alvarez-Mora et al. | Comprehensive molecular testing in patients with high functioning autism spectrum disorder | |
Mueller et al. | Common genetic variants in FOXP2 are not associated with individual differences in language development | |
Adegbola et al. | Monoallelic expression of the human FOXP2 speech gene | |
Thier et al. | GABAA receptor‐and GABA transporter polymorphisms and risk for essential tremor | |
Leitão et al. | Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X | |
Subaran et al. | Novel variants in ZNF34 and other brain‐expressed transcription factors are shared among early‐onset MDD relatives | |
Zhang et al. | Child development and structural variation in the human genome | |
Strom et al. | A streamlined approach to Prader-Willi and Angelman syndrome molecular diagnostics |